Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages F Ahsan, IP Rivas, MA Khan, AIT Suárez Journal of controlled release 79 (1-3), 29-40, 2002 | 727 | 2002 |
Medical use of cannabinoids AI Fraguas-Sánchez, AI Torres-Suárez Drugs 78 (16), 1665-1703, 2018 | 314 | 2018 |
Cannabidiol reduces ethanol consumption, motivation and relapse in mice A Viudez‐Martínez, MS García‐Gutiérrez, CM Navarrón, ... Addiction biology 23 (1), 154-164, 2018 | 147 | 2018 |
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy DHP De La Ossa, A Ligresti, ME Gil-Alegre, MR Aberturas, J Molpeceres, ... Journal of controlled release 161 (3), 927-932, 2012 | 119 | 2012 |
Insights into the effects of the endocannabinoid system in cancer: a review AI Fraguas‐Sánchez, C Martín‐Sabroso, AI Torres‐Suárez British journal of pharmacology 175 (13), 2566-2580, 2018 | 111 | 2018 |
New trends in the therapeutic approach to metastatic colorectal cancer J Sánchez-Gundín, AM Fernández-Carballido, L Martínez-Valdivieso, ... International journal of medical sciences 15 (7), 659, 2018 | 104 | 2018 |
CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer AI Fraguas-Sánchez, A Fernández-Carballido, R Simancas-Herbada, ... International journal of pharmaceutics 574, 118916, 2020 | 102 | 2020 |
Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme D Hernan Perez de la Ossa, M Lorente, ME Gil-Alegre, S Torres, ... PLoS One 8 (1), e54795, 2013 | 95 | 2013 |
Stability characteristics of cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies AI Fraguas-Sánchez, A Fernández-Carballido, C Martin-Sabroso, ... Journal of Chromatography B 1150, 122188, 2020 | 82 | 2020 |
PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: In vitro and in ovo assessment AI Fraguas-Sánchez, AI Torres-Suárez, M Cohen, F Delie, D Bastida-Ruiz, ... Pharmaceutics 12 (5), 439, 2020 | 81 | 2020 |
Current status of nanomedicine in the chemotherapy of breast cancer AI Fraguas-Sánchez, C Martín-Sabroso, A Fernández-Carballido, ... Cancer chemotherapy and pharmacology 84 (4), 689-706, 2019 | 80 | 2019 |
Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters J Aparicio-Blanco, V Sebastián, JP Benoit, AI Torres-Suárez European Journal of Pharmaceutics and Biopharmaceutics 134, 126-137, 2019 | 77 | 2019 |
In vitro screening of nanomedicines through the blood brain barrier: A critical review J Aparicio-Blanco, C Martín-Sabroso, AI Torres-Suárez Biomaterials 103, 229-255, 2016 | 68 | 2016 |
Cannabidiol enhances the passage of lipid nanocapsules across the blood–brain barrier both in vitro and in vivo J Aparicio-Blanco, IA Romero, DK Male, K Slowing, L García-García, ... Molecular pharmaceutics 16 (5), 1999-2010, 2019 | 61 | 2019 |
Validation protocol of analytical methods for finished pharmaceutical products C Sanchez, AI Torres Suarez, ME Gil Alegre, MM Obregon Sanchez, ... STP Pharma Pratiques 3 (3), 197-202, 1993 | 60 | 1993 |
Glioblastoma multiforme and lipid nanocapsules: a review J Aparicio-Blanco, AI Torres-Suarez Journal of biomedical nanotechnology 11 (8), 1283-1311, 2015 | 59 | 2015 |
Embolization therapy with microspheres for the treatment of liver cancer: State-of-the-art of clinical translation A Pérez-López, C Martín-Sabroso, L Gómez-Lázaro, AI Torres-Suárez, ... Acta Biomaterialia 149, 1-15, 2022 | 55 | 2022 |
Effects of cannabidiol plus naltrexone on motivation and ethanol consumption A Viudez‐Martínez, MS García‐Gutiérrez, AI Fraguas‐Sánchez, ... British journal of pharmacology 175 (16), 3369-3378, 2018 | 53 | 2018 |
Phyto-, endo-and synthetic cannabinoids: Promising chemotherapeutic agents in the treatment of breast and prostate carcinomas AI Fraguas-Sánchez, A Fernández-Carballido, AI Torres-Suárez Expert opinion on investigational drugs 25 (11), 1311-1323, 2016 | 52 | 2016 |
Actively targeted nanomedicines in breast cancer: from pre-clinal investigation to clinic AI Fraguas-Sánchez, I Lozza, AI Torres-Suárez Cancers 14 (5), 1198, 2022 | 50 | 2022 |